Sequent Scientific completes acquisition of 15% stake in Fendigo BV

Sequent Scientific completes acquisition of 15% stake in Fendigo BV

Oct 09, 2020 06:10 IST capital market

Sequent Scientific has completed the acquisition of 15% stake from Servatius Justinus Cornelius Maria Van Der Heijden in Fendigo BV through Alivira Animal Health, Ireland, Wholly Owned Subsidiary of the Company.

Consequently, Fendigo BV has become a Wholly Owned Subsidiary of the Company.

Powered by Capital Market - Live News

Related Story